Princess Ogbogu, MD | |
2050 Kenny Rd, Suite 2200, Columbus, OH 43221-3502 | |
(614) 293-4925 | |
(614) 293-5503 |
Full Name | Princess Ogbogu |
---|---|
Gender | Female |
Speciality | Allergy/immunology |
Experience | 24 Years |
Location | 2050 Kenny Rd, Columbus, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992954390 | NPI | - | NPPES |
2528661 | Medicaid | OH |
Facility Name | Location | Facility Type |
---|---|---|
Rainbow Babies And Childrens Hospital | Cleveland, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Hospitals Medical Group Inc | 4789682493 | 1466 |
News Archive
The Food and Drug Administration is about to make it easier for you to understand both the benefits and risks of a prescription medication, it was revealed at the Second Annual Medical Liaison Seminar sponsored here by Scientific Advantage LLC.
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough.
Porter Adventist Hospital is happy to announce that the Porter Breast Center, a regional destination for comprehensive breast care and part of the Centura Health Cancer Network, has been reaccredited by the American College of Surgeons, National Accreditation Program for Breast Centers with a three-year full accreditation.
› Verified 4 days ago
Entity Name | Osu Internal Medicine Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740231448 PECOS PAC ID: 5496651408 Enrollment ID: O20031210000658 |
News Archive
The Food and Drug Administration is about to make it easier for you to understand both the benefits and risks of a prescription medication, it was revealed at the Second Annual Medical Liaison Seminar sponsored here by Scientific Advantage LLC.
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough.
Porter Adventist Hospital is happy to announce that the Porter Breast Center, a regional destination for comprehensive breast care and part of the Centura Health Cancer Network, has been reaccredited by the American College of Surgeons, National Accreditation Program for Breast Centers with a three-year full accreditation.
› Verified 4 days ago
Entity Name | University Hospitals Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
The Food and Drug Administration is about to make it easier for you to understand both the benefits and risks of a prescription medication, it was revealed at the Second Annual Medical Liaison Seminar sponsored here by Scientific Advantage LLC.
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough.
Porter Adventist Hospital is happy to announce that the Porter Breast Center, a regional destination for comprehensive breast care and part of the Centura Health Cancer Network, has been reaccredited by the American College of Surgeons, National Accreditation Program for Breast Centers with a three-year full accreditation.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Princess Ogbogu, MD 700 Ackerman Rd, Suite 570, Columbus, OH 43202-1559 Ph: (614) 293-4925 | Princess Ogbogu, MD 2050 Kenny Rd, Suite 2200, Columbus, OH 43221-3502 Ph: (614) 293-4925 |
News Archive
The Food and Drug Administration is about to make it easier for you to understand both the benefits and risks of a prescription medication, it was revealed at the Second Annual Medical Liaison Seminar sponsored here by Scientific Advantage LLC.
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough.
Porter Adventist Hospital is happy to announce that the Porter Breast Center, a regional destination for comprehensive breast care and part of the Centura Health Cancer Network, has been reaccredited by the American College of Surgeons, National Accreditation Program for Breast Centers with a three-year full accreditation.
› Verified 4 days ago
Anh Dao, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 420 N James Rd, Columbus, OH 43219 Phone: 614-257-5200 | |
Dr. Christopher David Brooks, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 915 Olentangy River Rd Fl 4, Columbus, OH 43212 Phone: 614-366-3687 Fax: 614-293-9698 | |
Abner H Bagenstose Iii, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4830 Knightsbridge Blvd, Ste C, Columbus, OH 43214 Phone: 614-459-4949 Fax: 614-459-4951 | |
Dr. Donald L Mcneil, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8080 Ravines Edge Ct Ste 100, Columbus, OH 43235 Phone: 614-846-5944 Fax: 855-656-7325 | |
Thomas A Kiefer, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 500 E Main St, Ste. 110, Columbus, OH 43215 Phone: 614-233-9200 Fax: 614-233-9901 | |
Arthur E Varner, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 355 E Campus View Blvd, Suite 180, Columbus, OH 43235 Phone: 614-840-1688 Fax: 614-840-1689 | |
Dr. Grace Y Ryu, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8080 Ravines Edge Ct, Columbus, OH 43235 Phone: 614-846-5944 Fax: 614-846-6504 |